首页> 外文期刊>Critical care : >Inhibition of lectin-like oxidized low-density lipoprotein receptor-1 reduces leukocyte adhesion within the intestinal microcirculation in experimental endotoxemia in rats
【24h】

Inhibition of lectin-like oxidized low-density lipoprotein receptor-1 reduces leukocyte adhesion within the intestinal microcirculation in experimental endotoxemia in rats

机译:抑制凝集素样氧化型低密度脂蛋白受体-1降低了大鼠内毒素血症大鼠肠道微循环内的白细胞粘附

获取原文
           

摘要

IntroductionLectin-like oxidized low-density lipoprotein receptor-1 (LOX-1), the major endothelial receptor for oxidized low-density lipoprotein, is also involved in leukocyte recruitment. Systemic leukocyte activation in sepsis represents a crucial factor in the impairment of the microcirculation of different tissues, causing multiple organ failure and subsequently death. The aim of our experimental study was to evaluate the effects of LOX-1 inhibition on the endotoxin-induced leukocyte adherence and capillary perfusion within the intestinal microcirculation by using intravital microscopy (IVM).MethodsWe used 40 male Lewis rats for the experiments. Ten placebo-treated animals served as a control. Thirty animals received 5 mg/kg lipopolysaccharide (LPS) intravenously. Ten endotoxemic rats remained untreated. In 10 LPS animals, we administered additionally 10 mg/kg LOX-1 antibodies. Ten further LPS animals received a nonspecific immunoglobulin (rat IgG) intravenously. After 2 hours of observation, intestinal microcirculation was evaluated by using IVM; the plasma levels of monocyte chemoattractant protein-1 (MCP-1) and tumor necrosis factor-alpha (TNF-α) were determined; and LOX-1 expression was quantified in intestinal tissue with Western blot and reverse-transcription polymerase chain reaction (PCR).ResultsLOX-1 inhibition significantly reduced LPS-induced leukocyte adhesion in intestinal submucosal venules (P < 0.05). At the protein and mRNA levels, LOX-1 expression was significantly increased in untreated LPS animals (P < 0.05), whereas in animals treated with LOX-1 antibody, expression of LOX-1 was reduced (P < 0.05). MCP-1 plasma level was reduced after LOX-1 antibody administration.ConclusionsInhibition of LOX-1 reduced leukocyte activation in experimental endotoxemia. LOX-1 represents a novel target for the modulation of the inflammatory response within the microcirculation in sepsis.
机译:简介凝集素样氧化型低密度脂蛋白受体-1(LOX-1)是氧化型低密度脂蛋白的主要内皮受体,也参与白细胞募集。脓毒症中的全身白细胞活化是不同组织微循环受损的关键因素,从而导致多器官功能衰竭并随后死亡。我们的实验研究旨在通过活体显微镜(IVM)评估LOX-1抑制对内毒素诱导的肠道微循环内白细胞粘附和毛细血管灌注的影响。方法我们使用40只雄性Lewis大鼠进行实验。十只安慰剂治疗的动物作为对照。 30只动物静脉注射5 mg / kg脂多糖(LPS)。十只内毒素血症大鼠未接受治疗。在10只LPS动物中,我们额外施用了10 mg / kg LOX-1抗体。另外十只LPS动物静脉内接受了非特异性免疫球蛋白(大鼠IgG)。观察2小时后,使用IVM评估肠道微循环;测定血浆单核细胞趋化蛋白-1(MCP-1)和肿瘤坏死因子-α(TNF-α)的水平。 Western blot和逆转录聚合酶链反应(PCR)定量检测肠组织中LOX-1的表达。结果,LOX-1抑制显着降低了LPS诱导的肠黏膜下小静脉白细胞黏附(P <0.05)。在蛋白质和mRNA水平上,未处理的LPS动物的LOX-1表达显着增加(P <0.05),而用LOX-1抗体治疗的动物中LOX-1的表达降低(P <0.05)。服用LOX-1抗体后MCP-1血浆水平降低。结论LOX-1的抑制可降低实验性内毒素血症中的白细胞活化。 LOX-1代表了脓毒症微循环内炎症反应调节的新靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号